Why Chemistry Expertise Is Essential in Medical Device Manufacturing
Fundamental chemistry is changing the way companies manufacture medical devices. From surgical catheters and metered dose inhalers to diagnostic equipment, industry innovators are taking a technical approach to deliver better solutions.
It’s all about science. And finding a knowledgeable materials partner to guide you in your quest for new ideas is a great place to start. At Chemours, our technology team is working with customers across several medical applications to drive science-based solutions.
In this expert interview, VP of Technology Zeru Tekie talks about how Chemours is helping reshape the medical market. Watch now to get an inside look at these topics and more:
- Ways the team approaches innovation
- How fluoropolymers are impacting device design
- Providing sources for quality raw materials
Let’s solve the seemingly unsolvable, together.
Click Here to opt-in to receive occasional email from Chemours
Transcript
00:00:00 foreign and Welcome to our expert interview with techie our vice president of technology for the advanced performance Materials Division at Commerce techie how are you doing this afternoon how are you doing I'm doing great thanks for taking the time to talk with us today start off how would you describe
00:00:29 Kimora's approach to Innovation yeah comoros approaches Innovation based on Market back what we call marketback Innovation and what we mean by that is we start from the market and from our customers and identify what the market need is and then that becomes basically an input art Innovation process we Galvanize our Innovation organization
00:00:55 to respond to that need and work to basically satisfy what that market needs and what our customer need is and so when you're approaching a really complex technological requirement how do you think about meeting or closing the gaps in materials so the way we look at that is you know we try to understand what the need is in terms of material
00:01:19 needs like I said you know because we start from the market and from our customers we work with our you know marketing organization to Define what we call ctq's critical quality that specific material have to need so usually it is uh related around the property of the material that is required for that specific application the market needs
00:01:45 and once we know that then you know we use our ulti multi-disciplinary team in foreign chemistry Material Science and of course chemical mechanical analytical engineering competency that we have in the organization to see how we can adapt our materials and innovate new materials to meet that market need
00:02:10 what does comoros do in understanding fundamental chemistry and how does that translate into meeting needs in the medical market today yeah comoros has a deep root in fluorine chemistry and Material Science so through our history of over 60 years of foreign chemistry and the Material Science Background we look deep into understanding at fundamental level what the challenge
00:02:36 that we are facing based on VOC from our customers and then apply those toolboxes basically we we have a number of tools in our toolbox and those are as I initially know the multi-disciplinary you know competencies that we have in the organization so we we pull on them to see how we can solve that problem so that's how we approach it and and our approach is
00:02:58 always a fundamental approach we would like to solve those problems at a fundamental level from chemistry and Material Science Prospect what is different about how kimura's approaches some complex challenges around sourcing quality raw materials yeah Commerce approaches uh complex raw material supply issues by being directly vertically integrated when you look at
00:03:24 Commerce his Commodus is one of the few companies that is vertically integrated all the way from the raw material which is Spar in this case calcium fluoride that's mined from various Minds in the world all the way to the polymer production it's fully integrated from spark to HF and to all the intermediate products and all the way to the to the final products therefore by doing that
00:03:48 we have full control of our supply chain and control of our raw materials to provide materials for the medical Market in addition commercials also had a very diverse you know geographical location for production so we have production facilities in the US production facilities in Europe and the Asia Pacific so that allows us also to serve customers across the globe with a
00:04:14 significant you know Supply security from satellite perspective and Switching gears a little bit what is your favorite application of a Commerce product in a medical device and why yeah my favorite application is the neonatal application where we have our nepheum membranes used for conditioning of gas samples from neonatal babes this is basically a medical application where
00:04:43 you know continuous monitoring of oxygen of neonatal babes is used in hospitals and that you know you know air sample have to be conditioned to trim of the moisture and nepheon is used to do that unless you do that basically the the oxygen measurement doesn't work so to see that you know comoros contributes to the well-being of uh you know neonatal babes is is very humbling and and very
00:05:10 you know satisfying to see so that that's one of my favorite applications the fact that you know we are doing our part you know for the world well-being of humankind in order so Switching gears a little bit how do you see the regulatory environment or landscape for Flora polymers changing and how do you think that might impact medical devices over the next few years
00:05:34 or decades yeah definitely I mean the regulatory pressures are increasing in the world today and and partly is because of the you know Legacy issues related to you know uh basically pifas uh you know contamination in the world uh and uh when you look at that there is a significant stringent regulatory you know framework being developed across
00:06:00 the world and I think you know we understand that and tomorrows have established its CRC goals corporate responsibility commitment specifically around you know fluorinated Organics and Mission we have committed ourselves to produce you know fluorated organic emission by 99 and above by 2030 and we are well on our way in achieving that we have invested you know a significant
00:06:26 amount of capital in our production facilities to minimize our admission floral polymers are as I say very inert they are not mobile they are not available therefore you know they are not toxic therefore if they are responsibly produced you know they can really help us to maintain in our way of life and then also continuously to improve it so life for everyone across
00:06:50 the floor so there is currently regulatory framework being put forward in Europe I think you know we are looking at that our position is you know floral polymers needs to be fully dorigated from that restriction because of the reasons I mentioned I think the key is you know to making chloropolymer sustainable is a responsible manufacturing and what we mean by that
00:07:17 is minimizing the emission that comes from the production of photopolymers and and that's what we are doing with our CRC commitment in our case and at the same time also is uh you know we have to also continuously to work around the end of life for a polymers around circularity and this is also an area of high interest for us and we are actually working on R D programs to recycle as
00:07:43 much as we can at the end of life the floral Masada producer today so if we address the end of life and then address the manufacture inside of it through responsible manufacturing I think for polymers can be responsibly produced and how do you see kimura's evolving over the next few years from an innovation perspective in medical device markets and in others
00:08:06 so in line with that you know also as you will look into medical devices miniaturization that's also where we see in our workflow polymers can provide the medical device companies you know an advantage from using less material because from electrical property because of their Superior dielectric and uh you know discretion loss properties you can use less floral polymers than any other
00:08:31 material in the application of medical devices so we believe you know our materials will be also favored in that market space and finally what do we at kimura's want to know from the medical device Market uh we at Commodus like to know from the device Market you know what are the material challenges the material needs they have as they drive their Innovation
00:08:56 so as I indicated before uh Commodus is a market back Innovation company and therefore we like to hear from our customers in the medical devices you know what are the challenges they are facing from materials satisfaction as they push innovation in their industry therefore you know I take this opportunity to call on the device the medical device industry to contact us
00:09:20 and and engage Us in helping them Drive their Innovation and commerce We believe We succeed by making our customers successful therefore we have a very collaborative Innovation culture and we seek you know input and guidance from our customers to drive our Innovation and the for my ask is you know you contact us and engage us in your Innovation Pipeline and uh you know
00:09:48 challenge us with your material needs and you will find a willing partner that is willing to work with you to uh you know deliver the what you need for your innovation all right thanks so much techie for taking the time to talk with us this afternoon we really appreciate it and for those of you watching if you'd like to contact us please visit comores.com
00:10:12 medical or reach out via email at medical.mc commores.com thank you and have a great afternoon